Accredited Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
C.H. Robinson
CHRW
|
+$8.32M |
| 2 |
WisdomTree Emerging Markets High Dividend Fund
DEM
|
+$5.61M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$2.56M |
| 4 |
Graco
GGG
|
+$629K |
| 5 |
IBM
IBM
|
+$348K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$1.47M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.22M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$1.01M |
| 4 |
Wells Fargo
WFC
|
+$907K |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$419K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 6.6% |
| 2 | Consumer Staples | 3.08% |
| 3 | Technology | 1.99% |
| 4 | Materials | 1.21% |
| 5 | Healthcare | 1.08% |
Similar funds
Accredited Investors's Q1 2014 Portfolio in Review
As of Q1 2014, Accredited Investors held 61 positions worth $299M, up 4.8% from $286M the previous quarter. Its ten largest holdings account for 87% of the portfolio.
Accredited Investors deployed $13.5M of net new capital in Q1 2014, opening 4 new positions and adding to 29 existing holdings. Its largest new stake was C.H. Robinson: 152,708 shares worth $8M.
By sector, the portfolio is most concentrated in Industrials at 6.6% of assets, up from 4% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was iShares Russell Mid-Cap Growth ETF, an estimated $1.47M trimmed.
- Accredited Investors's largest Q1 2014 buy was C.H. Robinson: 152,708 shares worth $8M.
- Accredited Investors added most to WisdomTree Emerging Markets High Dividend Fund in Q1 2014, an estimated $5.61M increase.
- Accredited Investors's biggest Q1 2014 reduction was iShares Russell Mid-Cap Growth ETF, cutting an estimated $1.47M.
- Accredited Investors's ten largest holdings make up 87% of its $299M portfolio in Q1 2014.
- Accredited Investors opened 4 new positions and closed 0 in Q1 2014.
- Accredited Investors's portfolio value rose 4.8% quarter-over-quarter to $299M.
Based on Accredited Investors's 13F filing for Q1 2014, filed 7 May 2014.